Stem Cells Spin (WAR:SCS) Change In Inventory: zł-0.01 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:SCS Stem Cells Spin SA WAR:SCS
26 GF Score
Price zł0.52
GF Value zł0.10
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Stem Cells Spin Change In Inventory?

Stem Cells Spin WAR:SCS 26 Change In Inventory is zł-0.01 Mil as of Mar. 2026. GuruFocus rates WAR:SCS with a GF Score™ of 26/100 and a GF Value™ of zł0.10 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Stem Cells Spin's change in inventory for the quarter that ended in Mar. 2026 was zł-0.01 Mil. It means Stem Cells Spin's inventory increased by zł0.01 Mil from Dec. 2025 to Mar. 2026 .

Stem Cells Spin's change in inventory for the fiscal year that ended in Dec. 2025 was zł-0.01 Mil. It means Stem Cells Spin's inventory increased by zł0.01 Mil from Dec. 2024 to Dec. 2025 .

Stem Cells Spin's Total Inventories for the quarter that ended in Mar. 2026 was zł0.61 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Stem Cells Spin's Days Inventory for the quarter that ended in Mar. 2026 was 54,841.25.

Inventory Turnover measures how fast the company turns over its inventory within a year. Stem Cells Spin's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Stem Cells Spin's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 85.86.

Stem Cells Spin  (WAR:SCS) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Stem Cells Spin's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0.601/0.001*365 / 4
=54,841.25

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Stem Cells Spin's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0.001 / 0.601
=0.00

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Stem Cells Spin's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0.601 / 0.007
=85.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stem Cells Spin Change In Inventory Related Terms

Stem Cells Spin Change In Inventory Historical Data

* Premium members only.

The historical data trend for Stem Cells Spin's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stem Cells Spin Change In Inventory Chart

Stem Cells Spin Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 -0.00 0.02 -0.01 -0.01

Stem Cells Spin Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.01 -0.01 0.01 -0.01
WAR:SCS
26GF Score
Stem Cells Spin SA WAR:SCS
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stem Cells Spin Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of zł-0.01 Mil mean?
Stem Cells Spin (WAR:SCS) has a Change In Inventory of zł-0.01 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Stem Cells Spin and its competitors.
Is Stem Cells Spin's Change In Inventory too high?
Stem Cells Spin's current Change In Inventory is zł-0.01 Mil. Overall, Stem Cells Spin has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Stem Cells Spin's Change In Inventory compare to VRTX and REGN?
Stem Cells Spin's Change In Inventory of zł-0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Stem Cells Spin and its competitors. Stem Cells Spin's current Change In Inventory is zł-0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stem Cells Spin stock overvalued right now?
Based on GuruFocus' analysis, Stem Cells Spin (WAR:SCS) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.10, compared to a current price of zł0.52 — trading 415% above its estimated fair value. The current Change In Inventory is zł-0.01 Mil. Stem Cells Spin's overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Stem Cells Spin (WAR:SCS), the current Change In Inventory is zł-0.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stem Cells Spin (WAR:SCS) Overvalued in 2026?

Based on GuruFocus' analysis, Stem Cells Spin stock appears to be overvalued. The current stock price of zł0.52 is trading 415% above its estimated GF Value™ of zł0.10. GuruFocus considers Stem Cells Spin to be Significantly Overvalued.

Key valuation signals for WAR:SCS:

  • Change In Inventory: zł-0.01 Mil
  • GF Value™: zł0.10 vs. price of zł0.52 (415% above fair value)
  • GF Score™: 26/100 with 5 warning signs

No single metric tells the full story. See the WAR:SCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stem Cells Spin Business Description

Address Ulica Konopnickiej 15 b, Wroclaw, POL, 51-141
Stem Cells Spin SA is a biotechnology company. The company is engaged in the development, production, marketing, and sale of natural regenerative products for the dermocosmetic and veterinary care markets, as well as applications for the human and veterinary medical industry. Its products include NHAC Biocervin MIC-1, Revitacell, PRS MIC-1, and Velvetyna.
26GF Score

Get the complete analysis for WAR:SCS

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.52
Price
zł0.10
GF Value